← Leaderboards
Kevin Chun-Kai Wang
Stanford University
$2,470,594
Attributed
$2,470,594
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $765.2K · FY2011–23$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,470,594 · 3
By mechanism
R01$1,581,107 · 1
R61$760,962 · 1
K08$128,525 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Ahmet F. Coskun$3,955,082
- Ali Shariati$2,463,738
- Clint L Miller$7,435,883
- Nidhi Bhutani$8,915,723
- Judith Frydman$27,331,037
Others in their field
Top investigators on “Genetic Transcription”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$69,905,031
- Bing Ren · Ludwig Institute For Cancer Research$61,600,123
- Richard M Myers · Hudson-Alpha Institute For Biotechnology$54,253,356
- Richard Gibbs · Baylor College Of Medicine$53,550,246
- John A Tainer · Scripps Research Institute$51,251,962
- Deepak Srivastava · J. David Gladstone Institutes$50,027,907
Research focus
Genetic TranscriptionChromatinComplexMolecularProteinsEpigenetic ProcessMaintenanceCellsRegulator GenesPhenotypeMediatingInsightBiologyResponseAffectEpigenetic RegulationEventEmbryonic Stem CellEmbryoGene ExpressionMammalian CellDevelopmental ProcessDevelopmental DiseaseDiabetes Mellitus
Grant awards (8)
Transcriptional and Epigenetic Control of Pluripotency and Self-Renewal by Honey Bee Royalactin and its human structural analog$396,083
R01 · FY2023 · GM · contact PI
Transcriptional and Epigenetic Control of Pluripotency and Self-Renewal by Honey Bee Royalactin and its human structural analog$395,528
R01 · FY2022 · GM · contact PI
Transcriptional and Epigenetic Control of Pluripotency and Self-Renewal by Honey Bee Royalactin and its human structural analog$395,002
R01 · FY2021 · GM · contact PI
Targeted therapeutic modulation of inflammatory cytokines through manipulation of noncoding RNA regulation of innate immunity in atopic dermatitis$370,214
R61 · FY2021 · AR · contact PI
Transcriptional and Epigenetic Control of Pluripotency and Self-Renewal by Honey Bee Royalactin and its human structural analog$394,494
R01 · FY2020 · GM · contact PI
Targeted therapeutic modulation of inflammatory cytokines through manipulation of noncoding RNA regulation of innate immunity in atopic dermatitis$390,748
R61 · FY2019 · AR · contact PI
Transcriptional regulation of chromatin modifying complexes by noncoding RNAs$9,887
K08 · FY2012 · AR · contact PI
Transcriptional regulation of chromatin modifying complexes by noncoding RNAs$118,638
K08 · FY2011 · AR · contact PI